FIGURE 4-8. Patent Class 536/23.


Patent Class 536/23.1 (DNA/RNA fragments) application pendency by quarter, 1997-2002. NOTE: Pendency is calculated based on original file date and issue date for all issued patents in Class 536/23.1. Overall pendency is calculated by USPTO and also includes an estimate of the time from filing date to abandonment of the application. A = Utility and written description guidelines implemented.

From: 4, Trends in the Patenting and Licensing of Genomic and Protein Inventions and Their Impact on Biomedical Research

Cover of Reaping the Benefits of Genomic and Proteomic Research
Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation, and Public Health.
National Research Council (US) Committee on Intellectual Property Rights in Genomic and Protein Research and Innovation; Merrill SA, Mazza AM, editors.
Washington (DC): National Academies Press (US); 2006.
Copyright © 2006, National Academy of Sciences.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.